DHRS2
Dehydrogenase/reductase SDR family member 2, mitochondrial
Also known as: DHRS2_HUMAN, HEP27, SDR25C1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q13268
- Gene
- DHRS2
- Ensembl
- ENSG00000100867
- Chromosome
- 14
- Canonical length
- 280 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Mitochondria
OverviewNCBI Gene
This gene encodes a member of the short-chain dehydrogenases/reductases (SDR) family, which has over 46,000 members. Members of this family are enzymes that metabolize many different compounds, such as steroid hormones, prostaglandins, retinoids, lipids and xenobiotics. Alternative promoter use and alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2017]
Canonical amino-acid sequenceUniProt
280 residues, UniProt reviewed canonical sequence.
>Q13268|DHRS2
1 MLSAVARGYQ GWFHPCARLS VRMSSTGIDR KGVLANRVAV VTGSTSGIGF AIARRLARDG
61 AHVVISSRKQ QNVDRAMAKL QGEGLSVAGI VCHVGKAEDR EQLVAKALEH CGGVDFLVCS
121 AGVNPLVGST LGTSEQIWDK ILSVNVKSPA LLLSQLLPYM ENRRGAVILV SSIAAYNPVV
181 ALGVYNVSKT ALLGLTRTLA LELAPKDIRV NCVVPGIIKT DFSKVFHGNE SLWKNFKEHH
241 QLQRIGESED CAGIVSFLCS PDASYVNGEN IAVAGYSTRLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against DHRS2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.3
- Highest tissue expression
- 418 nTPM
Expression across tissuesHPA
Tissue
- urinary bladder: 418 nTPM
- breast: 316 nTPM
- salivary gland: 92 nTPM
- ovary: 90 nTPM
- liver: 26 nTPM
- spleen: 18 nTPM
Single-cell type
- urothelial cells: 3,414 nCPM
- prostatic club cells: 558 nCPM
- prostatic hillock cells: 465 nCPM
- papillary tip epithelial cells: 325 nCPM
- ovarian stromal cells: 53 nCPM
- pancreatic acinar cells: 35 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- pons: 3.2 nTPM
- hypothalamus: 2 nTPM
- midbrain: 2 nTPM
- hippocampal formation: 0.5 nTPM
- medulla oblongata: 0.5 nTPM
- cerebral cortex: 0.3 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about DHRS2.
Disease | ImmuneIEDB
Conditions an epitope on DHRS2 was assayed in.
- invasive ductal carcinoma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.48
- gnomAD pLI
- 0
- gnomAD missense Z
- -1.17
- DepMap mean gene effect
- -0.06
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- C21-steroid hormone metabolic process
- cellular response to oxidative stress
- electron transport chain
- myeloid dendritic cell differentiation
- negative regulation of apoptotic process
- negative regulation of cell population proliferation
- response to toxic substance
Molecular functions
- carbonyl reductase (NADPH) activity
- oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of DHRS2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads DHRS2 as an antibody target. Whether an autoantibody or antibody against DHRS2 could matter depends on whether native DHRS2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
DHRS2 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label DHRS2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...